SCHOTT Pharma AG & Co. KGaA (1SXP) — Net Asset Quality Index
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Net Asset Quality Index of 54.9% as of September 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.44 Billion minus total liabilities of €650.00 Million yields net assets of €792.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of SCHOTT Pharma AG & Co. KGaA for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
SCHOTT Pharma AG & Co. KGaA Net Asset Quality Index Over Time (2020–2024)
This chart shows how SCHOTT Pharma AG & Co. KGaA's Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2024, the index stands at 54.9%, representing net assets of €792.27 Million against total assets of €1.44 Billion EUR. For live market cap and overall valuation, see 1SXP market cap overview.
Annual Net Asset Quality Index for SCHOTT Pharma AG & Co. KGaA (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See SCHOTT Pharma AG & Co. KGaA (1SXP) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 54.9% | €792.27 Million | €1.44 Billion | €650.00 Million | ▼ -1.3 pp |
| 2023 | 56.2% | €692.18 Million | €1.23 Billion | €539.65 Million | ▼ -3.1 pp |
| 2022 | 59.3% | €709.04 Million | €1.20 Billion | €487.46 Million | ▲ +2.6 pp |
| 2021 | 56.7% | €419.42 Million | €739.89 Million | €320.48 Million | ▲ +3.7 pp |
| 2020 | 53.0% | €315.66 Million | €596.02 Million | €280.36 Million | — |